Vertex Pharmaceuticals Inc / Ma

Mirae Asset Global Investments Co., Ltd. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

174,347

Value ($000)

79,042

Weight

0.2%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	79,042	0.2%	174,347	12/31/2025
2025 Q3	11/3/2025	59,160	0.2%	151,056	9/30/2025
2025 Q2	7/21/2025	64,371	0.2%	144,588	6/30/2025
2025 Q1	4/24/2025	69,547	0.3%	143,318	3/31/2025
2024 Q4	1/27/2025	48,423	0.2%	119,549	12/31/2024
2024 Q3	10/23/2024	47,346	0.2%	102,285	9/30/2024
2024 Q2	7/30/2024	43,598	0.2%	92,269	6/30/2024
2024 Q1	5/1/2024	104,991	0.2%	300,856	3/31/2024
2023 Q4	1/24/2024	120,715	0.2%	296,678	12/31/2023
2023 Q3	10/26/2023	110,790	0.2%	318,600	9/30/2023
2023 Q2	8/10/2023	97,676	0.2%	277,568	6/30/2023
2023 Q1	5/4/2023	89,763	0.2%	284,899	3/31/2023
2022 Q4	2/9/2023	88,316	0.2%	305,822	12/31/2022
2022 Q3	11/10/2022	92,670	0.2%	319,967	9/30/2022
2022 Q2	8/15/2022	94,603	0.2%	335,722	6/30/2022
2022 Q1	5/10/2022	84,685	0.2%	324,500	3/31/2022
2021 Q4	2/8/2022	62,663	0.1%	285,187	12/31/2021
2021 Q3	11/15/2021	44,954	0.1%	247,830	9/30/2021
2021 Q2	8/11/2021	34,224	0.1%	169,739	6/30/2021
2021 Q1	5/13/2021	71,147	0.2%	331,087	3/31/2021
2020 Q4	2/10/2021	120,657	0.4%	510,524	12/31/2020
2020 Q3	11/12/2020	53,540	0.3%	198,285	9/30/2020
2020 Q2	8/11/2020	50,857	0.3%	175,183	6/30/2020
2020 Q1	5/12/2020	62,879	0.5%	264,251	3/31/2020
2019 Q4	2/12/2020	19,060	0.1%	87,057	12/31/2019